Literature DB >> 20738761

Risk of recurrent venous thromboembolism after stopping treatment in cohort studies: recommendation for acceptable rates and standardized reporting.

C Kearon1, A Iorio, G Palareti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20738761     DOI： 10.1111/j.1538-7836.2010.03991.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN： 1538-7836            Impact factor:   5.824


× No keyword cloud information.
  20 in total

Review 1.  Managing pulmonary embolism using prognostic models: future concepts for primary care.

Authors:  Geert-Jan Geersing; Ruud Oudega; Arno W Hoes; Karel G M Moons
Journal:  CMAJ       Date:  2011-12-05       Impact factor: 8.262

Review 2.  Anticoagulating patients with high-risk acquired thrombophilias.

Authors:  Leslie Skeith
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

Review 3.  Who should get long-term anticoagulant therapy for venous thromboembolism and with what?

Authors:  Marc Alan Rodger; Gregoire Le Gal
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2018-11-30

4.  Stopping anticoagulation in a woman with unprovoked venous thromboembolism.

Authors:  Faizan Khan; Grégoire Le Gal; Marc A Rodger
Journal:  CMAJ       Date:  2017-09-05       Impact factor: 8.262

Review 5.  Who should get long-term anticoagulant therapy for venous thromboembolism and with what?

Authors:  Marc Alan Rodger; Gregoire Le Gal
Journal:  Blood Adv       Date:  2018-11-13

6.  Prevalence of risk factors for venous thromboembolism in the Italian population: results of a cross-sectional study from the Master Registry.

Authors:  Walter Ageno; Giancarlo Agnelli; Davide Imberti; Marco Moia; Gualtiero Palareti; Riccardo Pistelli; Melina Verso
Journal:  Intern Emerg Med       Date:  2011-06-10       Impact factor: 3.397

7.  D-dimer testing to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: follow the rules!

Authors:  Alessia Abenante; Francesca Zuretti; Cristina Dedionigi; Flavio Tangianu; Francesco Dentali
Journal:  Intern Emerg Med       Date:  2019-12-07       Impact factor: 3.397

Review 8.  Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?

Authors:  Fionnuala Ní Áinle; Barry Kevane
Journal:  Blood Adv       Date:  2020-11-10

Review 9.  Extended anticoagulation for unprovoked venous thromboembolism: a majority of patients should be treated.

Authors:  Clive Kearon
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300

Review 10.  Which patients with unprovoked VTE should receive extended anticoagulation? the minority.

Authors:  Marco P Donadini; Walter Ageno
Journal:  J Thromb Thrombolysis       Date:  2011-04       Impact factor: 2.300
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.